Experience That Matters
Our team consists of proven industry professionals supported by a trusted advisory group of clinical experts all with a common goal of advancing our mission toward a physiological treatment pathway.
President + CEO
Dom Messerli, MBA
Dom Messerli is the visionary Founder, President, and CEO of Lenoss Medical, pioneering biologic technology for the physiological treatment of osteoporotic spinal column fractures.
Prior to founding Lenoss Medical, as Director of R&D, Dom led efforts in the acquisition, integration, and transformation of Johnson & Johnson's Spine organization, DePuy Synthes Spine. Prior to JNJ, Dom held leadership positions across Product Development and Marketing during the growth of Synthes Spine to over $0.5B in revenue.
With his advanced leadership skills to develop high-performing, collaborative teams, Dom has led global teams through multiple product commercialization launches and successfully led his division from early initiation to a strong market leadership position with an impressive cadence of innovative and successful product introductions, increasing global annual sales from $10M to $150M.
With a philosophy that ingenuity lies in simplicity, Dom the inventor can be found on many relevant patents related to medical devices currently in use across spine specialties. Dom received his Bachelor of Science in Mechanical Engineering degree from the University of Bern in Switzerland and an Executive MBA from Penn State University with admission to the international honor society for collegiate schools of business, Beta Gamma Sigma. Currently, Dom serves on the Board of Directors for RI Bio and is the Chairman of the Board for Lenoss Medical.
Dom is an avid sailor and enjoys sailing in Narraganset Bay.
Spine Sales Executive Consultant
Product Development Engineer
Commercial Marketing Consultant
Human Resources Consultant
Spine Regulatory/Quality Consultant
Dom Messerli, Board Chairman
Wayne Allen, Board Director
Bob Minutti, Board Director
Thorne Sparkman, Board Observer
Lydia Schroter, Board Observer